Nanjing Pharmaceutical Company Limited’s Net Profit Rose 17.3% in 2022

Nanjing Pharmaceutical Company Limited (南京医药股份有限公司) (600713.SH) reported a net profit of 715.9 million yuan in 2022, up 17.3% year-on-year.

Meanwhile, the company posted 50.2 billion yuan in revenue, up 11.3% year-on-year.

At the end of the reporting period, it had 31.7 billion yuan in total assets and 25 billion yuan in total liabilities, with a liability-to-asset ratio of 78.9%.